ilmscore | Prediction Details
"Clidogil generally is being given to people uh having uh you know heart related issues. Mainly it is uh to um to have reduced number you know to basically it is to avoid clothes. So maybe in decreasing a bit of plate count and you know and clothes are being avoided this medicine is being given to heart patients in your case this increases your risk"
By Finance With Sharan | December 17, 2025 | Correct
From video
Why Healthy People Still Get Cancer & Heart Attacks | Genetic Risks Explained Ft. Dr. Sajeev | FWS84 01:09:41 - 01:10:17
Interpreted Prediction
The drug Clopidogrel (Clidogil), typically used for heart patients to prevent clots, can increase risks for individuals with specific genetic profiles and should be avoided if a pharmacogenetic test indicates this risk.
AI Evaluation Notes
The prediction that Clopidogrel (Clidogil) can increase risks for individuals with specific genetic profiles is accurate. Research confirms that genetic variations affect how individuals respond to Clopidogrel, and pharmacogenetic testing can help identify those at higher risk.

Prediction Details

Topic
Pharmacogenetics and Drug Response

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.